Clinitech Laboratory IPO Subscription Status

Clinitech Laboratory IPO Subscription - Day-3 Subscription at 38.96 times

Clinitech Laboratory IPO will close on 29 July. Shares of Clinitech Laboratory are likely to be listed on 1 Aug. Shares of Clinitech Laboratory  will make trading debut on BSE SME platform

On 29 July 2024, Clinitech Laboratory IPO received bids for 2,22,55,200 shares much more than the 5,71,200 shares available. It means Clinitech Laboratory IPO was oversubscribed by 38.96 times by the end of day 3.

Here are the subscription details for Clinitech Laboratory IPO as of Day 3:

Clinitech Laboratory IPO subscription was primarily driven by retail investors on final day, followed by High Net-Worth Individuals (HNIs) and Non-Institutional Investors (NIIs), QIBs and HNIs/NIIs increase their subscriptions in the final hours of the last day. Overall subscription figures exclude the anchor portion and market-making segment of the IPO. 

QIBs are large institutional investors like mutual funds and insurance companies, while HNIs/NIIs are wealthy individuals and smaller institutions.

Subscription Status of Clinitech Laboratory IPO for Days 1, 2, and 3

On day 1, Clinitech Laboratory IPO was subscribed 2.61 times. By day 2, the subscription status had risen to 6.03 times and on day 3, it reached 38.96 times.
 

Here are the subscription details for Clinitech Laboratory IPO by category as of Day 3:

Data Source: BSE

For Clinitech Laboratory IPO  Market Makers subscribed 1x with 31,200 shares offered and bid, totaling ₹0.30 crore. HNIs/NIIs subscribed 23.28x. Retail Investors subscribed 49.61x for 3,01,200 shares, with bids totaling ₹143.44 crore. Overall, the IPO oversubscribed 38.96x 

Clinitech Laboratory IPO Subscription - Day-2 Subscription at 6.03 Times

Clinitech Laboratory IPO will close on 29 July. Shares of Clinitech Laboratory are likely to be listed on 1 August. Shares of Clinitech Laboratory  will make trading debut on BSE SME platform

On 26 July 2024, Clinitech Laboratory IPO received bids for 34,45,200 shares much more than the 5,71,200 shares available. This means that the Clinitech Laboratory IPO was oversubscribed by 6.03 times by the end of the 2nd day.

Clinitech Laboratory IPO subscription was primarily driven by retail investors on the first day, followed by High Net-Worth Individuals (HNIs) and Non-Institutional Investors (NIIs)., QIBs and HNIs/NIIs increase their subscriptions in the final hours of the last day. Overall subscription figures exclude the anchor portion and market-making segment of the IPO. 

QIBs are large institutional investors like mutual funds and insurance companies, while HNIs/NIIs are wealthy individuals and smaller institutions.

Here are the subscription details for Clinitech Laboratory IPO as of Day 2:

On day 1,  Clinitech Laboratory IPO was subscribed 2.61 times. By day 2, the subscription status had risen to 6.03 times. Clinitech Laboratory IPO received good interest. High Net-Worth Individuals (HNIs) and Non-Institutional Investors (NIIs) subscribed 1.33 times, while Retail Investors showed significant interest with a subscription rate of 10.10 times. Overall, the IPO was subscribed 6.03 times till now. Final subscription status will be clear end of day 3.